{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:16:05Z","timestamp":1778681765150,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU12014\/ 2"],"award-info":[{"award-number":["MC_UU12014\/ 2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12014\/8"],"award-info":[{"award-number":["MC_UU_12014\/8"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00034\/4"],"award-info":[{"award-number":["MC_UU_00034\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:17:45Z","timestamp":1709871465000},"page":"2429-2437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Virus-like particles of louping ill virus elicit potent neutralizing antibodies targeting multimers of viral envelope protein"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-0801","authenticated-orcid":false,"given":"Rapeepat","family":"Tandavanitj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-949X","authenticated-orcid":false,"given":"Chayanee","family":"Setthapramote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuditta","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Sanchez-Velazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0276-8040","authenticated-orcid":false,"given":"Mara","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2024.03.008_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcpa.2017.09.002","article-title":"120 years of louping-ill research: an historical perspective from the archive of the Journal of Comparative Pathology","volume":"157","author":"Buxton","year":"2017","journal-title":"J Comp Pathol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2024.03.008_b0010","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1099\/vir.0.062356-0","article-title":"Louping ill virus: an endemic tick-borne disease of Great Britain","volume":"95","author":"Jeffries","year":"2014","journal-title":"J Gen Virol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2024.03.008_b0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/jcpa.2001.0533","article-title":"The pathogenicity of louping ill virus for mice and lambs","volume":"126","author":"Sheahan","year":"2002","journal-title":"J Comp Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.008_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0021-9975(75)90063-8","article-title":"Experimental infection of red grouse with louping-ill virus (flavivirus group). I. The Viraemia and antibody response","volume":"85","author":"Reid","year":"1975","journal-title":"J Comp Pathol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.03.008_b0025","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1469-0691.2004.01022.x","article-title":"Tick-borne virus diseases of human interest in Europe","volume":"10","author":"Charrel","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.03.008_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcpa.2018.09.004","article-title":"A fatal case of louping-ill in a dog: immunolocalization and full genome sequencing of the virus","volume":"165","author":"Dagleish","year":"2018","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2024.03.008_b0035","article-title":"Suspected tick-borne flavivirus meningoencephalomyelitis in dogs from the United Kingdom: 6 cases (20xx-20xx)","author":"Gonzalo-Nadal","year":"2023","journal-title":"J Small Anim Pract"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.008_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.09.015","article-title":"Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy","volume":"361","author":"Grard","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.008_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"6529","key":"10.1016\/j.vaccine.2024.03.008_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.008_b0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.vaccine.2024.03.008_b0060","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1128\/JVI.77.21.11357-11366.2003","article-title":"Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus","volume":"77","author":"Allison","year":"2003","journal-title":"J Virol"},{"issue":"40","key":"10.1016\/j.vaccine.2024.03.008_b0065","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2010.07.055","article-title":"Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate","volume":"28","author":"Ohtaki","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.008_b0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12985-021-01611-2","article-title":"The key amino acids of E protein involved in early flavivirus infection: viral entry","volume":"18","author":"Hu","year":"2021","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.008_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.03.008_b0080","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.008_b0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41467-018-02882-0","article-title":"Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody","volume":"9","author":"Fuzik","year":"2018","journal-title":"Nat Commun"},{"issue":"33","key":"10.1016\/j.vaccine.2024.03.008_b0090","doi-asserted-by":"crossref","first-page":"12400","DOI":"10.1073\/pnas.0603488103","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.vaccine.2024.03.008_b0095","doi-asserted-by":"crossref","first-page":"e02132-18","DOI":"10.1128\/JVI.02132-18","article-title":"Molecular basis of a protective\/neutralizing monoclonal antibody targeting envelope proteins of both tick-borne encephalitis virus and louping ill virus","volume":"93","author":"Yang","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.03.008_b0100","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1038\/ncomms13679","article-title":"Neutralization mechanism of a highly potent antibody against Zika virus","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.vaccine.2024.03.008_b0105","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1128\/JVI.01145-06","article-title":"The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation","volume":"80","author":"Hilton","year":"2006","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.008_b0110","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/JVI.03162-12","article-title":"A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity","volume":"87","author":"Edmonds","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.03.008_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1472-6750-8-41","article-title":"In vivo site-specific biotinylation of proteins within the secretory pathway using a single vector system","volume":"8","author":"Predonzani","year":"2008","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2024.03.008_b0120","doi-asserted-by":"crossref","first-page":"e01415-20","DOI":"10.1128\/JVI.01415-20","article-title":"Zika virus-like particles bearing a covalent dimer of envelope protein protect mice from lethal challenge","volume":"95","author":"De Lorenzo","year":"2020","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.008_b0125","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41598-017-01097-5","article-title":"Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells","volume":"7","author":"Slon Campos","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2024.03.008_b0130","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.73.7.5605-5612.1999","article-title":"Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E","volume":"73","author":"Allison","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.008_b0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0034-5288(94)90056-6","article-title":"Recombinant vaccinia virus expressing PrM and E glycoproteins of louping ill virus: induction of partial homologous and heterologous protection in mice","volume":"57","author":"Venugopal","year":"1994","journal-title":"Res Vet Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.008_b0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0168-1702(92)90014-Z","article-title":"Louping ill virus envelope protein expressed by recombinant baculovirus and vaccinia virus fails to stimulate protective immunity","volume":"26","author":"Shiu","year":"1992","journal-title":"Virus Res"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2024.03.008_b0145","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1099\/0022-1317-81-3-749","article-title":"Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine","volume":"81","author":"Fleeton","year":"2000","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.008_b0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1097-2765(01)00206-4","article-title":"Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus","volume":"7","author":"Ferlenghi","year":"2001","journal-title":"Mol Cell"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:32:36Z","timestamp":1778679156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24002937"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like particles of louping ill virus elicit potent neutralizing antibodies targeting multimers of viral envelope protein","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}